This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

Mako: Blood Is Flowing in the Street

NEW YORK ( TheStreet) -- If you're a current Mako Surgical (MAKO) investor, Monday night's sales release must have felt like an operation filled with complications and every side effect has your name on it.

Florida-based medical device maker Mako Surgical announced that Mako sold nine RIO systems in the second-quarter, well below Wall Street's expectation. The sales figure for the first half of 2012, is a disappointing 15 units.

On a somewhat positive note, utilization rates are in line and suggest doctor acceptance of the value provided. The company's proprietary MAKOplasty procedures for second quarter rose 66% year over year for a total of 2,590. For the first six months of 2012, a total of 4,887 procedures were performed, a 71% increase year over year.

A best-case scenario is a delay in sales until later this year, but it doesn't appear to be the case as Mako has adjusted 2012 anticipated sales from 52 to 58 systems down to 42 to 48 RIO systems.

Based on my experience with gap downs following disappointing sales similar to MAKO's, the odds favor greater downside with Wednesday or Thursday marking the short-term low. After a bounce, expect further downside pressure. It's not quite time to wish for a price above the previous closing of $20, but MAKO does have strong support near $14.

Friday or early next week will likely find bargain hunters picking up shares cheap to flip over. If Thursday appears to be closing below Wednesday's low, I may join with the bargain hunters for a quick one night stand.

MAKO Surgical was downgraded to Neutral from Buy at Summer Street. Michael Matson, a New York-based analyst with Mizuho Securities USA has a current price target of $15. I believe Michael is optimistic to believe Mako will move higher and stay above $15 anytime soon.

Bargain hunters and short sellers covering positions could push the price up about 20% in relation to the gap down price. Looking at the chart, I expect short-term resistance near $15.

Round numbers often attract like a price magnet and repel, causing a bounce. Expect a lot of volume to trade near $15 a share today, but also be prepared for a closing under the opening price, and more than a 50% chance of a close under the open. Short interest is a massive 50% of the float. There is a reason why short sellers are considered the smart money and nothing demonstrates it like Mako.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
MAKO $0.00 0.00%
DELL $0.00 0.00%
ZMH $117.52 0.00%
SYK $92.25 0.00%
AAPL $124.43 0.00%


DOW 17,776.12 -200.19 -1.11%
S&P 500 2,067.89 -18.35 -0.88%
NASDAQ 4,900.8850 -46.5560 -0.94%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs